Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CNVS
CNVS logo

CNVS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Cineverse Corp (CNVS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.570
1 Day change
-2.28%
52 Week Range
7.390
Analysis Updated At
2026/05/08
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

CNVS is not a clear buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some improving strategic narrative and bullish analyst target revisions, but the current price action is only mildly constructive, options activity is extremely call-skewed but too thin to be meaningful, and the latest quarterly financials still show steep revenue and earnings declines. For an impatient investor who does not want to wait for a better entry, this is still a hold rather than an immediate buy.

Technical Analysis

CNVS is trading at 2.64, just above its pivot level of 2.528 and below R1 at 2.692. MACD histogram is positive at 0.0259, but it is contracting, which weakens momentum. RSI_6 at 62.97 is neutral-to-mildly bullish, not overbought, and moving averages are converging, suggesting a range-bound setup rather than a strong uptrend. The short-term technical picture is slightly positive, but not strong enough to justify an aggressive long-term entry today.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is extremely bullish on paper, with a very low open interest put-call ratio of 0.02 and zero put volume, but the data also shows zero option volume today and very low recent activity, so the signal is more skew than conviction. Implied volatility is high at 93.15%, while IV rank is low at 13.16 and IV percentile is 31.87, indicating elevated expected movement but not a strong premium-rich setup. Overall, options data leans bullish but lacks confirmation from active trading.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
10
Buy
4

Positive Catalysts

  • ["Benchmark upgraded CNVS to Buy from Speculative Buy and raised its price target to $12 from $9.", "Alliance Global raised its target to $10 from $6 and maintained a Buy rating.", "Analysts view recent acquisitions, including IndieCue and Giant Worldwide, as shifting Cineverse toward a more recurring, scalable, and less capital-intensive business model.", "News around Pan's Labyrinth screening in 4K at Cannes gives Cineverse a small event-driven publicity catalyst tied to AI-driven re-release technology."]

Neutral/Negative Catalysts

  • ["Latest quarter revenue fell 60.02% year over year.", "Net income remained negative and worsened year over year.", "EPS also declined sharply year over year.", "Hedge funds and insiders are both neutral, with no significant buying trends.", "No recent congress trading data is available to suggest influential support.", "The stock trend model suggests possible weakness over the next month."]

Financial Performance

In 2026/Q3, Cineverse reported revenue of 16.286 million, down 60.02% year over year, showing a major top-line decline. Net income was -1.013 million and EPS was -0.05, both worse than the prior year. The bright spot is gross margin, which improved to 61.61%, up 33.53% year over year. This indicates better unit economics, but the overall quarter still looks weak because growth is contracting sharply.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analyst sentiment has improved recently. Benchmark upgraded CNVS to Buy from Speculative Buy and set a $12 target, while Alliance Global raised its target to $10 and kept a Buy rating. The bullish case centers on Cineverse transitioning from lumpy revenue to a more recurring technology platform. Wall Street pros are clearly more constructive than before, but the bullish view is still based on a strategic turnaround story rather than proven consistent operating strength.

Wall Street analysts forecast CNVS stock price to rise
2 Analyst Rating
Wall Street analysts forecast CNVS stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.630
sliders
Low
6
Averages
7.5
High
9
Current: 2.630
sliders
Low
6
Averages
7.5
High
9
Benchmark
Speculative Buy -> Buy
upgrade
$9 -> $12
AI Analysis
2026-02-19
Reason
Benchmark
Price Target
$9 -> $12
AI Analysis
2026-02-19
upgrade
Speculative Buy -> Buy
Reason
As previously reported, Benchmark upgraded Cineverse to Buy from Speculative Buy with a price target of $12, up from $9. After the acquisition of IndiCue, an advertising technology company, Cineverse has "gone from lumpy, unpredictable revenue to a business model that is largely recurring/reoccurring and that solves a growing need in the evolving media landscape," the analyst tells investors. The firm's 20-times EBITDA multiple reflects both the shift to software and "an attempt to capture just how conservative we believe numbers will end up being," the analyst added.
Benchmark
Daniel Kurnos
Speculative Buy -> Buy
upgrade
$12
2026-02-19
Reason
Benchmark
Daniel Kurnos
Price Target
$12
2026-02-19
upgrade
Speculative Buy -> Buy
Reason
Benchmark analyst Daniel Kurnos upgraded Cineverse to Buy from Speculative Buy with a $12 price target.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CNVS
Unlock Now

People Also Watch